BetterLife Pharma’s BETR-001 Shows Promise for Depression Treatment
BetterLife Pharma has shared encouraging preclinical findings regarding BETR-001, a non-hallucinogenic compound aimed at treating psychiatric disorders. BETR-001 selectively activates…